839 related articles for article (PubMed ID: 25977174)
1. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Choi JD; Kwon K; Jang CS; Ro YT; Noh YH; Kim SY
Tumour Biol; 2016 Feb; 37(2):2285-97. PubMed ID: 26361955
[TBL] [Abstract][Full Text] [Related]
3. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
Zhang M; Luo SC
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
6. Integrative meta-analysis of multiple gene expression profiles in acquired gemcitabine-resistant cancer cell lines to identify novel therapeutic biomarkers.
Lee YS; Kim JK; Ryu SW; Bae SJ; Kwon K; Noh YH; Kim SY
Asian Pac J Cancer Prev; 2015; 16(7):2793-800. PubMed ID: 25854364
[TBL] [Abstract][Full Text] [Related]
7. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
9. Identification of common gene networks responsive to radiotherapy in human cancer cells.
Hou DL; Chen L; Liu B; Song LN; Fang T
Cancer Gene Ther; 2014 Dec; 21(12):542-8. PubMed ID: 25412644
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
[TBL] [Abstract][Full Text] [Related]
11. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the protein-protein interaction networks of differentially expressed genes in pulmonary embolism.
Wang H; Wang C; Zhang L; Lu Y; Duan Q; Gong Z; Liang A; Song H; Wang L
Mol Med Rep; 2015 Apr; 11(4):2527-33. PubMed ID: 25434468
[TBL] [Abstract][Full Text] [Related]
13. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
14. Ossification of the posterior longitudinal ligament related genes identification using microarray gene expression profiling and bioinformatics analysis.
He H; Mao L; Xu P; Xi Y; Xu N; Xue M; Yu J; Ye X
Gene; 2014 Jan; 533(2):515-9. PubMed ID: 24055420
[TBL] [Abstract][Full Text] [Related]
15. Identification of human prolactinoma related genes by DNA microarray.
Zhao L; Lin M; Wang S
J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
[TBL] [Abstract][Full Text] [Related]
16. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
17. Screening candidate genes associated with bladder cancer using DNA microarray.
Xu A; Wang C; Sun S
Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.
Kuang Z; Guo L; Li X
Mol Med Rep; 2017 Oct; 16(4):4685-4693. PubMed ID: 28791394
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
